BANK OF MONTREAL /CAN/ - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 64 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2017$4,000
-50.0%
8360.0%0.00%
Q4 2016$8,0000.0%8360.0%0.00%
Q3 2016$8,000
+60.0%
8360.0%0.00%
Q2 2016$5,0000.0%8360.0%0.00%
Q1 2016$5,0008360.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q4 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,000,000$7,330,0003.56%
Sio Capital Management, LLC 336,286$2,465,0001.69%
Opaleye Management Inc. 285,000$2,089,0001.03%
SENZAR ASSET MANAGEMENT, LLC 864,408$6,336,111,0000.92%
MENORA MIVTACHIM HOLDINGS LTD. 1,350,847$9,902,0000.74%
Ghost Tree Capital, LLC 150,000$1,100,0000.50%
PURA VIDA INVESTMENTS, LLC 102,000$748,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 380,000$2,785,0000.36%
J. Goldman & Co LP 474,810$3,480,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 948,934$6,956,0000.27%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders